Active Ingredient: MYCOPHENOLATE MOFETIL
Proprietary Name: MYHIBBIN
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 200MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216482
Product Number: 001
Approval Date: May 1, 2024
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
